Bleeding after cardiopulmonary bypass and protamine reactions
Stem
A 71-year-old man, 84 kg, is having a redo mitral valve replacement with two bypass grafts after 190 minutes of cardiopulmonary bypass. He is off bypass on low-dose epinephrine, and the full protamine dose is in. Twenty minutes later the surgeon reports oozing from every suture line. ACT is 131 seconds (baseline 118), temperature 35.6 °C, platelets 84,000, and fibrinogen 1.2 g/L.
Question
The field will not dry. How do you manage this bleeding?
Ideal answer
HeadlineI first make the surgeon rule out a surgical source, then treat the coagulopathy by numbers: heparin reversed, fibrinogen first, then platelets.
- Ask where, and fix the field conditions: a single bleeder needs a stitch; I warm him to normothermia and correct ionized calcium and pH.
- Prove the heparin is gone: ACT near baseline and a heparinase viscoelastic comparison; extra protamine only for residual heparin, because overdose itself impairs clotting.1
- Fibrinogen for this level with microvascular bleeding: below 1.5 g/L I give fibrinogen concentrate or cryoprecipitate.2
- Platelets when bleeding below 50,000 or on antiplatelets; he is long on bypass with dysfunctional platelets.2
- PCC only after fibrinogen is corrected; rFVIIa last.2
Watch for: chest-tube output, a field that dries, and filling pressures rising as the mediastinum fills.
Breaking down the answer
- Viscoelastic algorithm — TEG or ROTEM results arrive in 10–30 minutes and guided algorithms reduce transfusion and severe kidney injury;2 in five RCTs mortality fell from 8.9% to 4.4%.2 Changes if: no device, I use laboratory fibrinogen and platelets, not empiric plasma.
- Protamine dose — calculate against the initial heparin dose and keep the ratio below 1.0;2 its half-life is about 5 minutes,1 and heparin rebound with bleeding can appear hours later.3
- Why fibrinogen first — low fibrinogen is the commonest laboratory predictor of post-bypass bleeding;2 4 g of concentrate matched 10 units of cryoprecipitate in an RCT of 735 patients.2
- rFVIIa — a last resort for uncontrollable bleeding; prophylactic use raised stroke, and very low doses below 20 µg/kg are under study.2
- Protamine reactions — type I isolated hypotension from rapid injection, type II anaphylactic or anaphylactoid, type III pulmonary hypertension with RV failure.4 Slow infusion reduces them.1
- Who reacts — prior protamine or NPH insulin, fish allergy, vasectomy, severe LV dysfunction or abnormal pulmonary hemodynamics.3
Follow-up question
Two hours later in the ICU, products have normalized his viscoelastic tracing, but the chest tubes have drained 400 mL each hour, the epinephrine dose is climbing, and his CVP has risen from 10 to 17 mmHg. What do you do?
Follow-up answer
HeadlineThis is surgical bleeding, and possibly tamponade; I call the surgeon to re-explore now.
Rising CVP, falling pressure and climbing inotrope, with TEE findings, point to tamponade needing resternotomy.2 Early re-exploration improves survival.2 While the team assembles I transfuse to keep up, correct temperature, calcium, acid–base and dilution,2 and prepare for bedside sternal reopening if he arrests.
Pitfalls that cost points
- Treating every post-bypass ooze with plasma before knowing fibrinogen and platelets.
- Leaving cardiotomy suction running once protamine starts, which contaminates the circuit you may need again.
Rapid-fire
Q: How does a type III protamine reaction present? A: Sudden pulmonary hypertension and RV failure with hypotension; I stop protamine, give epinephrine and inhaled NO or milrinone for the RV, then re-heparinize for bypass or VA-ECMO.4
Q: How often do protamine reactions occur? A: Reported incidence ranges from 0.06% to 10.6%.4
Q: Why does more protamine not fix a prolonged ACT? A: Hypothermia, platelets, factor deficits and antithrombin also prolong it, and excess protamine worsens the coagulopathy.1
Q: Is prophylactic fibrinogen useful? A: No; give it only for a level below 1.5 g/L with ongoing microvascular bleeding.2
Numbers to know
| Item | Value |
|---|---|
| Fibrinogen trigger | <1.5 g/L with microvascular bleeding2 |
| Platelet trigger | <50,000 bleeding, or on antiplatelets2 |
| Protamine-to-heparin ratio | <1.0, by initial dose2 |
| Protamine half-life | ~5 min1 |
| Viscoelastic turnaround | 10–30 min2 |
| Fibrinogen 4 g | ≈ cryoprecipitate 10 units2 |
Links
- Cardiopulmonary bypass: conduct and separation, Cardiac tamponade, including post-cardiac surgery, Massive hemorrhage and transfusion, Anticoagulant reversal and inherited bleeding disorders, anaphylaxis
- Atlas: The 11 TEE views; Pericardial effusion and tamponade
- 2024 EACTS/EACTAIC patient blood management guideline; 2024 EACTS/EACTAIC/EBCP CPB guideline
Sources
- 1.2024 EACTS/EACTAIC/EBCP Guidelines on cardiopulmonary bypass in adult cardiac surgery · EACTS/EACTAIC/EBCP, 2024 · ebi.ac.ukInteract Cardiovasc Thorac Surg 2025;40:ivaf002; section 9.3 (anticoagulation, protamine management).
- 2.2024 EACTS/EACTAIC Guidelines on patient blood management in adult cardiac surgery in collaboration with EBCP · EACTS/EACTAIC/EBCP, 2024 · ebi.ac.ukEur J Cardiothorac Surg 2024;ezae352. Sections 4.3.2 (protamine), 5.1 (procoagulants), 5.2.2 (algorithm-guided therapy), 6.2 (re-exploration).
- 3.Protamine sulfate (AHFS monograph) · Drugs.com / ASHP · drugs.com
- 4.Protamine Reactions · OpenAnesthesia (IARS), 2025 · openanesthesia.org
Facts on this page were checked against these sources on Oct 22, 2026. Guidelines change; confirm doses against current institutional protocols.